Amir Khorrami Chokami
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity
CONGIU, CENZO;ONNIS, VALENTINA;DEPLANO, ALESSANDRO;BALBONI, GIANFRANCO;
2015-01-01
Abstract
By using SLC-0111 (4-fluorophenylureido-benzenesulfonamide), a sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor in Phase I clinical trials as an antitumor agent as lead molecule, a series of benzenesulfonamide derivatives incorporating ureido moieties was synthesized. The new compounds contain a 4-N-substituted piperazine fragment in which the ureido linker has been included, and were tested as inhibitors of the cytosolic human (h) hCA I and II isoforms, as well as the transmembrane, tumor-associated enzymes hCA IX and XII. Depending on the substitution pattern at the piperazine ring, low nanomolar inhibitors were detected against all four isoforms, making the new class of sulfonamides of interest for various pharmacologic applications.File | Dimensione | Formato | |
---|---|---|---|
BMCL_2015_CAI_supporting info.docx Solo gestori archivio
Descrizione: supplementary informations
Tipologia: altro documento allegato
Dimensione 28.03 kB
Formato Microsoft Word XML
|
28.03 kB | Microsoft Word XML | Visualizza/Apri Richiedi una copia |
BMCL_2015_CAI_supporting info2.xlsx Solo gestori archivio
Descrizione: supporting information 2
Tipologia: altro documento allegato
Dimensione 299.91 kB
Formato Microsoft Excel XML
|
299.91 kB | Microsoft Excel XML | Visualizza/Apri Richiedi una copia |
BMCL 2015_CAI.pdf Solo gestori archivio
Descrizione: Articolo principale Versione dell'editore
Tipologia: versione editoriale
Dimensione 1.75 MB
Formato Adobe PDF
|
1.75 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.